Widely prescribed, newer-generation antipsychotic drugs are no more effective for the treatment of schizophrenia in children and teens than older, cheaper drugs, a government-funded study shows.
Under the direction of the National Institute of Mental Health (NIMH), researchers compared two of the newer drugs, known as atypical antipsychotics, to an older-generation antipsychotic. They found no major differences in treatment outcomes, but big differences in side effects among young patients taking the newer and older drugs.
Newer Antipsychotics No Better in Kids
The Supreme Court on May 4 reinstated mail-order access to the widely used abortion drug mifepristone,...
At the MAHA Institute's "Mental Health & Overmedicalization Summit" in the nation's capital, the Health and...
Three people have died in an outbreak of a dangerous respiratory virus on a cruise ship...
